US1442851036 - Common Stock

Overall **CRS** gets a fundamental rating of **5** out of 10. We evaluated **CRS** against 155 industry peers in the **Metals & Mining** industry. Both the profitability and the financial health of **CRS** get a neutral evaluation. Nothing too spectacular is happening here. **CRS** is not priced too expensively while it is growing strongly. Keep and eye on this one!

In the past year **CRS** had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: **CRS** reported negative net income in multiple years.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 4.54% | ||

ROE | 9.72% | ||

ROIC | 6.98% |

ROA(3y)-2.53%

ROA(5y)-0.47%

ROE(3y)-5.4%

ROE(5y)-1.05%

ROIC(3y)N/A

ROIC(5y)N/A

With a decent **Profit Margin** value of **5.26%**, **CRS** is doing good in the industry, outperforming **70.32%** of the companies in the same industry.

In the last couple of years the **Profit Margin** of **CRS** has declined.

Looking at the **Gross Margin**, with a value of **16.86%**, **CRS** is in line with its industry, outperforming **53.55%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **CRS** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 8.85% | ||

PM (TTM) | 5.26% | ||

GM | 16.86% |

OM growth 3Y-10.3%

OM growth 5Y-9.66%

PM growth 3Y251.8%

PM growth 5Y-23.99%

GM growth 3Y-7.01%

GM growth 5Y-5.68%

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so **CRS** is destroying value.

Compared to 1 year ago, **CRS** has more shares outstanding

Compared to 5 years ago, **CRS** has more shares outstanding

Compared to 1 year ago, **CRS** has an improved debt to assets ratio.

The **Altman-Z score** of **CRS** (**3.41**) is better than **63.87%** of its industry peers.

The Debt to FCF ratio of **CRS** is **6.90**, which is on the high side as it means it would take **CRS**, **6.90** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **0.48** indicates that **CRS** is not too dependend on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.48 | ||

Debt/FCF | 6.9 | ||

Altman-Z | 3.41 |

ROIC/WACC0.8

WACC8.72%

The **Current ratio** of **CRS** (**2.90**) is comparable to the rest of the industry.

A Quick Ratio of **1.26** indicates that **CRS** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.9 | ||

Quick Ratio | 1.26 |

The **Earnings Per Share** has grown by an impressive **1480.95%** over the past year.

The earnings per share for **CRS** have been decreasing by **-14.45%** on average. This is quite bad

The **Revenue** has been growing slightly by **3.40%** on average over the past years.

EPS 1Y (TTM)1480.95%

EPS 3Y-19.32%

EPS 5Y-14.45%

EPS growth Q2Q553.85%

Revenue 1Y (TTM)26.44%

Revenue growth 3Y5.35%

Revenue growth 5Y3.4%

Revenue growth Q2Q7.79%

Based on estimates for the next years, **CRS** will show a very strong growth in **Earnings Per Share**. The EPS will grow by **78.26%** on average per year.

The **Revenue** is expected to grow by **8.49%** on average over the next years. This is quite good.

EPS Next Y244.5%

EPS Next 2Y104.89%

EPS Next 3Y78.26%

EPS Next 5YN/A

Revenue Next Year9.45%

Revenue Next 2Y8.69%

Revenue Next 3Y8.49%

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Based on the **Price/Earnings** ratio of **27.21**, the valuation of **CRS** can be described as expensive.

Based on the **Price/Earnings** ratio, **CRS** is valued a bit cheaper than 64.52% of the companies in the same industry.

The **Price/Forward Earnings** ratio is **16.34**, which indicates a correct valuation of **CRS**.

Based on the **Price/Forward Earnings** ratio, **CRS** is valued a bit cheaper than 69.03% of the companies in the same industry.

When comparing the **Price/Forward Earnings** ratio of **CRS** to the average of the S&P500 Index (**21.23**), we can say **CRS** is valued slightly cheaper.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 27.21 | ||

Fwd PE | 16.34 |

Compared to the rest of the industry, the **Enterprise Value to EBITDA** ratio of **CRS** is on the same level as its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 38.04 | ||

EV/EBITDA | 12.13 |

The low **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as **CRS**'s earnings are expected to grow with **78.26%** in the coming years.

PEG (NY)0.11

PEG (5Y)N/A

EPS Next 2Y104.89%

EPS Next 3Y78.26%

Compared to an average S&P500 **Dividend Yield** of **2.45**, **CRS**'s dividend is way lower than the S&P500 average.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.01% |

The dividend of **CRS** has a limited annual growth rate of **2.12%**.

Dividend Growth(5Y)2.12%

Div Incr Years0

Div Non Decr Years15

DP27.56%

EPS Next 2Y104.89%

EPS Next 3Y78.26%

**CARPENTER TECHNOLOGY**

NYSE:CRS (4/22/2024, 3:59:11 PM)

After market: 78.91 0 (0%)**78.91**

**+0.87 (+1.11%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryMetals & Mining

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap3.90B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.01% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 27.21 | ||

Fwd PE | 16.34 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)0.11

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 4.54% | ||

ROE | 9.72% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 8.85% | ||

PM (TTM) | 5.26% | ||

GM | 16.86% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.86

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.48 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.9 | ||

Quick Ratio | 1.26 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)1480.95%

EPS 3Y-19.32%

EPS 5Y

EPS growth Q2Q

EPS Next Y244.5%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)26.44%

Revenue growth 3Y5.35%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y